Organovo Holdings, Inc. (ONVO) Financials

ONVO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 8.9 million 2.7 million
2023-09-30 11.2 million 2.7 million
2023-06-30 20.3 million 5.0 million
2023-03-31 20.3 million 5.0 million

ONVO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.5 million 157000
2023-09-30 -3.2 million 675000
2023-06-30 -4.9 million 500000
2023-03-31 -4.9 million 500000

ONVO Net Income

No data available :(

ONVO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.3 million - 1.5 million
2023-09-30 7.6 million - 1.6 million
2023-06-30 16.0 million - 1.7 million
2023-03-31 - - 1.8 million

ONVO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 9.1 million
2023-09-30 8.7 million
2023-06-30 8.7 million
2023-03-31 8.7 million

ONVO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.4 million 2.2 million 14000
2023-09-30 27000 1.3 million 2.8 million 13000
2023-06-30 162000 5.4 million 2.5 million 85000
2023-03-31 162000 5.4 million 2.5 million -

ONVO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5000 72000
2023-09-30 - 70000
2023-06-30 162000 59000
2023-03-31 162000 -

ONVO

Price: $0.95

52 week price:
0.89
2.24

Earnings Per Share: -2.16 USD

P/E Ratio: -0.42

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 21800

Ebitda: -7.6 million

Market Capitalization: 10.1 million

Links: